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Abstract
Assisted reproduction techniques (ARTs) allow women of advanced reproductive age 
to become pregnant. One of the most frequent complications of ART is twin pregnancy. 
Cases where both factors are present represent a specially vulnerable population for 
obstetric complications and medical perinatal and post-partum consequences for both 
the mother and babies. Pre-existing medical conditions are more frequent at advanced 
age, and the pregnancy physiological changes and the high metabolic demand associated 
with a twin pregnancy may reveal or worsen any previous disease. A careful counselling 
process is very important in this population and certain obstetric interventions might 
be particularly addressed to it. Single embryo transfer should be strongly enforced in 
advanced age women to minimise risk for the mother and children.
Keywords: twin pregnancy, advanced maternal age, ART, obstetric complications, 
reproductive counselling, oocyte donation, obstetric care
1. Introduction
Dizygotic twin pregnancies are known to increase with age of the mother. Naturally conceived 
twins are thought to occur in a 0.3% rate in women under 25 years, 1.4% between 25 and 34, 
3% between 34 and 39, and 4.1% in women in their 40s or over [1]. We also know that at least 
50% of all twin pregnancies are conceived through ART and that this proportion is probably 
higher for women in their 40s. International guidelines affirm that maternal mortality associ-
ated with multiple births is 2.5 times that for singleton births [2]. Since obstetric and obstetric-
related medical complications are amplified in the case of women of advanced reproductive 
age and also in twin gestations, the combination represents a particularly vulnerable group.
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In Spain, for example, according to the 2013th ESHRE registry [3], a total of 56,704 treat-
ments were performed, 18,113 consisting in egg donation, which makes almost 32% of all 
treatments. The percentage of women older than 40 years undergoing treatment and arriving 
to egg aspiration was 15.7%, with a pregnancy rate of 29.9%, but a delivery rate of 9.5%. 
For egg donation programmes, the percentage of women over 40 increased to 66.9%, with a 
pregnancy rate of 48.4 and a delivery rate of 30.5%. This means that in 2013–2014, 4272 women 
over 40 carried and delivered a baby in Spain. The proportion of double embryo transfers 
was 71.5%, with 20.9% of twin deliveries in FIV/ICSI treatments and 24.6% in egg donation: 
around 982 twin deliveries in women over 40 in Spain in 2013. And this only counts for the 
pregnancies achieved through ART. This same registry suggests that the overall preterm birth 
rate for twins was 51%.
But, which age is “too old”? Can we set a threshold? Can we legislate against advanced repro-
ductive age? And, would this legislation only account for women seeking reproductive care? 
If we already know all these, why is it still happening? Can we, as a society, deny maternity 
to any woman? Can we afford this? What if maternity age continues to increase in the world? 
Should not this evolve with society? This chapter will raise many questions that, sorry, we 
would not probably able to answer.
2. Ethical issues in the reproduction clinic
2.1. Setting a threshold for treatment
In most countries, there is no legislation restricting maternal age. Some countries would not 
include women of advanced age in their public reproduction schemes, but the same restric-
tions usually do not apply to the private sector. And more importantly, in many countries, 
there is no restriction in the number of embryos being transferred to these women. Not only 
access cannot be denied but two and three embryos can also be transferred freely.
Classically, advanced maternal age has been defined as any woman conceiving after 35 years 
of age. Given the late reproductive trends, this threshold should now be reconsidered, as in 
developed countries it might include a high percentage of the pregnant population. Advanced 
maternal age nowadays might be considered as a woman conceiving after 40–43 years of age, 
which is the approximate age in which ovary ageing may have almost completely prevented 
spontaneous conception. However, although rare, spontaneous conception over 40s is pos-
sible, so is it fair to deny reproductive treatment to a woman whose same-age neighbour 
might have conceived spontaneously?
In this environment, most clinics set their own thresholds (or not at all) without much gov-
ernmental support. Very few clinics would accept to perform reproductive treatment on a 
woman older than 50, which represents an age in which more or less half of the female popu-
lation is menopausal. However, peri- and postnatal risk for the mother and the babies start 
increasing progressively much earlier than that. But when a clear guidance does not exist, 
decision making becomes somehow subjective, mainly considering our previous experiences. 
Can we impose our own personal opinion over a woman’s family desire?
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2.2. Counselling advanced reproductive age mothers
Autonomy principle involves that appropriately informed patients can decide whether they 
want to undergo or refuse a diagnostic test or treatment, accepting the benefits and risks 
of their decision. Following this principle, any woman seeking reproductive treatment after 
the age of 35, or more appropriately, after the age of 40, should be carefully informed about 
obstetrical complications and the health implication for them and the child. They should also 
be informed about preventive and treatment strategies that may be put in place to avoid 
them. When counselling women with pre-existing medical conditions, their head specialist 
should review the case and advise for or against pregnancy. It is very important to remember 
that certain medical conditions do contraindicate pregnancy, as they might lead to a life-
threatening situation.
2.3. Fertility in older mothers’ children
Although most causes of infertility are not genetic, it has been observed in a US population 
study that daughters from mothers older than 40 years are more likely to remain childless 
in their lifetime [4]. However, it is difficult to discern whether this is a “learnt” pattern or a 
true “inherited” infertility trait. In the same population, daughters from “old” mothers were 
at double risk for delivering twins than daughters from “young” mothers (OR = 2.1, 95% CI: 
0.8–5.4), although this difference was not statistically significant. This may suggest that delay-
ing childbirth might be perpetuated and worsen with time in our current society.
2.4. Oocyte donation programmes
Oocyte donation restores pregnancy possibility in women of advanced reproductive age and 
reduces the chances for implantation failure found among them. Most women seeking this 
treatment are happily married women, well-educated and high-income, and physically and 
psychologically healthy [5]. However, oocyte donation recipients experienced a higher risk 
of pregnancy complications largely due to advanced maternal age, particularly hyperten-
sive disorders and diabetes, and the risk increases with age [6]. The Ethics Committee of the 
American Society for Reproductive Medicine recommends women of advanced reproductive 
age undergo a comprehensive medical test to ascertain fitness for pregnancy in order to pre-
vent the rise of obstetric complications during pregnancy [7]. Multiple pregnancy is known 
to increase obstetrical and neonatal risks in women of all ages; therefore, it is particularly 
important to avoid a twin gestation in older mothers.
3. Reproduction treatment and advanced maternal age
3.1. Low ovarian reserve
The effect of age in the ovarian reserve is unavoidable. Although menopause is considered the 
end of the reproductive age in women, changes in the ovarian cycle take place many years prior 
to menopause. These changes may lead to a fertility dysfunction in women that decide to get 
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pregnant at an advanced age. The primary mechanism behind this process is the decrease of pri-
mordial follicle count in the ovary susceptible to developing a good-quality ovule. Classically, 
follicle count during menstrual cycle has been assessed using ultrasound. In addition, numer-
ous studies have reported changes in the hormone patterns associated with reproductive 
ageing, such as shortened follicular phase, elevated follicular phase oestrogen, and decreased 
luteal phase progesterone [8–13]. During the last decade, anti-Müllerian hormone (AMH) has 
emerged as an early biochemical marker able to predict the decrease in the ovarian reserve. Low 
AMH serum levels predict an altered folliculogenesis by inhibiting the recruitment of primor-
dial follicles and its sensitivity to FSH [14]. The reduction of AMH serum levels appears to be 
more strongly and more consistently correlated with age than the decrease number of antral 
follicles observed in the ovary by ultrasound, inhibin B levels, or FSH levels [15, 16].
3.2. Ageing uterus
In addition to changes observed in the ovarian reserve and quality of the oocytes, the uterus 
is an essential organ to achieve pregnancy. As in any other human organ, ageing also has 
an effect on the uterus of fertile women. Even though it is difficult to evaluate these changes 
in humans, animal studies indicate that older mice show an impaired artificially induced 
decidual response, probably due to reduced progesterone secretion [17–19]. Microscopic 
changes have also been confirmed, with more hyperaemia and higher vascular development 
and growth of the myometrium and stroma of young hamsters in comparison with the older 
ones [20]. Older mothers are also more likely to experience intrapartum complications and 
the rate of caesarean delivery is higher, suggesting that myometrial function is impaired by 
advanced maternal age [21]. The risk of stillbirth in mothers over the age of 40 is twice as high 
as younger mothers due to foetal chromosomal abnormalities, multiple pregnancy, obesity, 
pre-eclampsia, insulin-dependent diabetes, and multiple pregnancy [21, 22]. These evidences 
suggest that changes in the uterus in older women may have a reflection on fertility and the 
ability of maintaining a pregnancy.
3.3. Chromosomal abnormalities
Women who delay childbearing are at an increased risk of foetal chromosomal abnormalities. 
This occurs as a consequence of an error in chromosomal disjunction during maternal meiosis 
I or II, which has been reported as more frequent in advanced age women [23–25]. Among 
them, numeric chromosomal abnormalities seem to be more frequent than structural chro-
mosomal abnormalities. Chromosomal aneuploidies related to maternal age include trisomy 
21, trisomy 18, trisomy 13, triple X syndrome, and Klinefelter syndrome [26]. A recent study 
highlights that trisomy 21 showed an incidence rate of 11.34 out of 1000 cases at the age of 
35 years, 15.41 cases at the age of 40, and 37.04 cases at the age of 45. In addition, trisomy 18 
showed an incidence rate of 1.89 out of 1000 cases at the age of 35 years, 5.14 cases at the age 
of 40, and 37.04 cases at the age of 45. Nowadays, prenatal diagnostic techniques such as ultra-
sound and cell-free foetal DNA test allow professionals to make an early screening for foetal 
aneuploidy. However, invasive techniques remain the gold standard for definitive diagnosis, 
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with a risk of miscarriage per se of 0.35% (CI 95%: 0.07 to 0.63) following amniocentesis and 
0.35% (95% CI: -0.31 to 1.00) following chorionic villus sampling [27].
3.4. Oocyte donation
The use of donor oocytes in assisted reproduction techniques (ARTs) during the last decades 
has been a great advance for women whose reproductive dysfunction could not be treated 
otherwise. It was initially addressed for young women with premature ovarian failure. But 
this technique provides a valuable weapon to avoid age-related changes in the ovary, allow-
ing premenopausal and menopausal women to get pregnant and fulfil their reproductive 
desire with acceptable success rates [28–30]. Moreover, the use of oocytes from donors has 
numerous advantages, as it reduces the rate of aneuploidies and stillbirth in women of 
advanced age. Case reports of successful pregnancy and delivery in a 70-year-old patient 
with donated oocytes demonstrate that the uterus may be able to maintain pregnancy far 
beyond the age of menopause [21]. Women are delaying childbearing; it is likely that the 
percentage of women looking for donor oocytes will increase, as it has been in the last 
decade.
3.5. Strategies to reduce twin pregnancies in the elderly mother
Twins occur spontaneously, and we still do not understand the causes or the conditions 
under which an embryo decides to split in two. However, the vast majority of twin preg-
nancies, particularly in women of advanced reproductive age, happened as a result of 
ART. Women seeking reproductive treatment usually have been trying to conceive sponta-
neously for a long period of time, and many have undergone previous unsuccessful treat-
ments. Frustration, impatience, and economic costs are probably the main reasons why 
transfer of two and even three embryos is still a common practice in many countries [1]. This 
practice increases the chances of achieving pregnancy per embryo-transfer but also increases 
the chances of obtaining a multiple pregnancy. Multiple pregnancies have an important 
impact on the mothers’ and babies’ health as a consequence of medical and obstetric compli-
cations, and this carries an important economic burden for society, mainly due to preterm 
delivery, long hospital stay of the premature babies, and treatment of subsequent disabilities 
in the long term [31].
For obvious reasons, the main strategy to reduce the number of twin pregnancies in all 
women is the widespread use of the single embryo transfer (sET) during a fertility treatment. 
Our target should be to resemble the spontaneous twinning rate of embryos. Thanks to the 
development of vitrification, a fast freezing technique that increases post-thawed embryo 
survival rate, a single embryo can be transferred in a fresh cycle, while the rest will be trans-
ferred posteriorly in vitrified-thawed cycles without any loss of implantation potential [32]. 
The latest studies show the promising potential of sET to markedly reduce the risk of multiple 
pregnancy without affecting pregnancy outcomes. Even though sET might increase the time 
to pregnancy, minimising the risk of twin pregnancy becomes a huge advantage for public 
and individual health, particularly for elderly mothers.
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4. Physiological homeostasis changes that may affect elderly 
mothers’ health
During pregnancy, a series of physiological homeostatic changes take place in a woman’s 
body that activate numerous adaptive mechanisms, mainly cardiovascular, respiratory, and 
hemodynamic. These changes are essential for the evolution and progress of a normal preg-
nancy. Adaptive mechanisms can be compromised as a consequence of underlying diseases, 
which appear more frequently in women of advanced age.
The increase in cardiac output, extracellular volume, and arterial compliance and the 
decrease in arterial blood pressure (BP) and peripheral resistance are some of the cardio-
vascular changes that occur in pregnant mothers [33]. Mean BP decreases during pregnancy 
presenting its lower values in the middle of the second trimester and then it starts to increase 
reaching values comparable to non-pregnant women at the end of pregnancy. In addition, 
redistribution of blood flow to different organs is essential in order to cover for the higher 
metabolic requirements, and so venous return and cardiac output raise dramatically [34]. 
There are also hormonal factors that favour these changes to appear. Oestrogens and relaxin 
are both involved in the production of nitrous oxide (NO), which produces vasodilatation 
during pregnancy and facilitates the distribution of blood to key organs [35, 36]. Ageing is 
associated with structural changes in the vascular wall, which leads to loss of arterial elasticity 
and reduced arterial compliance. Cardiovascular adaptive mechanisms could be impaired in 
elderly mothers due to pre-existing hypertensive disorders or venous insufficiency; therefore, 
they are at high risk of suffering from complications such as preeclampsia and placental insuf-
ficiency, increasing morbidity and mortality for both the mother and the baby.
Modifications in the respiratory system also take place during pregnancy. Pulmonary func-
tion is affected by location and orientation changes of the airway and configuration of the tho-
rax due to the presence of the gravid uterus as well as hormonal effects. The elevation of the 
diaphragm decreases the lung’s vertical diameter and subsequently enlarges the transversal 
and anteroposterior diameters. The displacement of the diaphragm produces a progressive 
decline in expiratory reserve volume and residual volume. Progesterone, cortisol, and relaxin 
produce dilatation of the airway in pregnant women reducing pulmonary resistance [37]. 
Ageing is associated with structural changes not only in the chest bones and diaphragm but 
also in the lung tissue. The dilatation of the alveoli decreases the exchange surface increasing 
the residual volume and functional residual capacity. These physiological changes added to 
those typical from pregnancy can cause alterations in the ventilation-perfusion ratio in elderly 
mothers.
Dilatation of the renal pelvis and ureters is characteristic during pregnancy on account of the 
growth of the uterus and the effect of hormones, such as progesterone, that cause relaxation 
of the smooth muscle. This predisposes women to suffer from urinary tract infections during 
pregnancy. Renal function is also modified during this period with an increased blood flow 
and glomerular filtration up to 60% [38]. Precisely for that reason, we should be aware of 
any medical pre-existing renal dysfunction that can worsen during pregnancy. For example, 
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diabetes mellitus type 2 appears more often after the fourth decade of life and affects directly 
the renal function. Renal function–affected women need to be closely monitored during 
pregnancy.
These are only some of the major adaptive mechanisms in a woman’s body during pregnancy, 
but there are many more subtle changes that occur in this period. We should pay attention 
to any minimal sign of hemodynamic decompensation especially in pregnant women of 
advanced age who are more likely to suffer from diseases, previously undiagnosed, as a result 
of ageing of their organs.
5. Obstetric complications in twin pregnancy related to age
There are not many studies specifically evaluating obstetric outcomes in twin pregnancies 
in advanced maternal age, and most of them are retrospective. These studies usually set 
the threshold for advanced maternal age at the “classic” 35 years, but in current times, this 
threshold should probably be reconsidered. A recent study by Zhu et al. [39] showed that, in 
twin pregnancies, advanced maternal age was associated with a higher risk of post-partum 
haemorrhage, gestational diabetes, and preterm delivery. However, other studies do not 
demonstrate any significantly increased risk over controls [40].
Much more attention has been paid to the obstetric complications in twins resulting from 
ART. Particularly, they are at increased risk of placenta praevia, caesarean section birth, pre-
term birth, and low birth weight [41]. Again, other studies showed no significant differences 
[42]. What we can be sure of is that twin pregnancies represent a huge demand for the body 
and that they do come with a higher obstetrical risk. Advanced age mothers’ physical fitness 
necessarily cannot be the same to compensate for this fact.
5.1. Preterm delivery
We defined preterm delivery as birth prior to 37 weeks of gestation. Preterm birth complicates 
5–18% of pregnancies and is the leading cause of neonatal death and the second cause of 
childhood death below the age of 5 years [43]. We should distinguish between preterm deliv-
eries medically indicated secondary to foetal or maternal complications during pregnancy, 
such as preeclampsia, intrauterine growth restriction, or gestational diabetes, from those that 
occur after spontaneous onset of labour. Many studies have described multiple risk factors for 
preterm birth [44–47], although others propose this entity is a syndrome caused by multiple 
pathologic processes [43].
Twin pregnancy has been classically described as one of the risk factors associated with pre-
term birth. Although multiple gestation accounts for only 2–3% of all births, this type of gesta-
tion constitute 17% of births before 37 weeks of gestation and 23% of birth before 32 weeks 
[48]. The mechanism for preterm birth in multiple gestations may be related to the increased 
uterine distension; however, some studies suggest that the increased amount of oestrogen, 
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progesterone, and sex steroids compared with singleton pregnancies could play an important 
role in the physiopathology of the syndrome [49, 50].
The effect of maternal age also influences the risk of preterm birth. Some studies suggest that 
even after adjusting for cofounders such as hypertension, diabetes, race, and mode of concep-
tion, maternal age over 40 years is an independent risk factor for preterm delivery [47, 51].
The widespread availability of reproductive technology has increased the percentage of mul-
tiple gestations and preterm delivery as an aftermath. Therefore, it is our duty to inform 
women of the risk of this type of pregnancies and enforce the use of the different strategies in 
order to achieve singleton pregnancy.
5.2. Preeclampsia
As we have seen before, mean BP decreases during the first and second trimesters secondary 
to the reduction of peripheral resistances and starts to increase reaching values similar to 
non-pregnant women in the third trimester.
Preeclampsia (PE) is a hypertensive disorder that appears during pregnancy. PE is a major 
obstetric complication that causes 15–20% of maternal mortality worldwide, especially in 
developing countries [52]. It is characterised by the presence of high BP (> 140/90 mmHg) and 
proteinuria (> 300 mg/dL) beyond 20 weeks of pregnancy. The finding of higher values of BP 
before this stage of pregnancy is considered chronic hypertension, which can also worsen in 
the second half of pregnancy, with what we call superimposed preeclampsia. The physiopa-
thology of this multisystemic disorder still remains unknown.
In the last decades, several aetiologies have been described. Some authors suggest that it 
appears secondary to an abnormal vascular response of the uterine blood vessels to tropho-
blast invasion, causing platelet aggregation and endothelial dysfunction [52–54]. The increase 
of BP during pregnancy can also have an effect on the foetus, developing complications such 
as low birth weight, oligoamnios, and intrauterine growth restriction [54, 55]. In addition, 
preeclampsia is considered severe when it affects multiple organs, finally producing pulmo-
nary oedema, renal failure, seizures, thrombocytopenia, elevation of liver enzymes, and dis-
seminated intravascular coagulation [54].
The rate of preeclampsia ranges between 2 and 7% in healthy nulliparous women [54, 56, 57]. 
These rates increase to 14% in twin pregnancies [58]. Preeclampsia is regarded as typical of the 
first pregnancy. In spite of this, the risk of developing preeclampsia in subsequent pregnancies 
raises till 18% [58].
Numerous studies proposed several risk factors to classify a specific group of women who 
are at a high risk of developing preeclampsia, including nulliparity, older age, chronic hyper-
tension, and diabetes mellitus [59–61]. Other studies indicate that, after adjusting for other 
cofounders, women of advanced maternal age are 1.5 times more likely to have preeclampsia 
compared to those under 35 years of age [62]. Multiple pregnancy is a moderate risk factor for 
the development of pre-eclampsia during pregnancy. Women with multiple pregnancy, who 
have any of the other moderate risk factors for pre-eclampsia (first pregnancy, age 40 years 
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or older, pregnancy interval of more than 10 years, BMI of 35 kg/m2 or more at first visit, or 
family history of preeclampsia), should receive a daily aspirin dose [63].
As we have seen before, single-embryo transfer is the main technique to reduce the rate of 
twin pregnancies. We should focus our effort on identifying those women with pre-existing 
medical conditions who are predisposed to suffer PE and, if applying ART, enforce the impor-
tance of achieving a singleton gestation to avoid adverse perinatal outcomes.
5.3. Gestational diabetes
Gestational diabetes mellitus (GDM) is a diabetic state diagnosed for the first time in preg-
nancy. It is one of the most common metabolic disorders in pregnancy. GDM complicates 
3–5% of pregnancies and it is considered a risk factor for adverse perinatal outcomes, such as 
macrosomia, shoulder dystocia, cerebral palsy, and foetal death [64–66]. It is defined as basal 
glucose ≥126 mg/dl (7.0 mmol/l), HbA1c ≥ 6.5% (47.5 mmol/mol), or glucose levels ≥200 mg/dl 
(11.1 mmol/l) at any time of the day or screen positive for any of the GDM tests available [67].
Diabetes predisposes pregnant women to suffer urine infections, hypertensive disorders, and 
prematurity. It is well known that pregestational diabetes can cause foetal malformations, 
intrauterine growth restriction, stillbirth, and congenital heart disease probably due to vas-
cular alterations in mothers. Both gestational and pregestational diabetes have effects on the 
foetus secondary to hyperinsulinemia, such as macrosomia, polyhydramnios, and foetal lung 
immaturity that may cause foetal neonatal distress.
Women of advanced maternal age are at a higher risk of developing GDM [68]. Twin preg-
nancies have also been related to GDM [69]. The development of GDM usually indicates a 
reduced pancreatic reserve in the pregnant mother and is a marker of pre-diabetes, putting 
them at a higher risk of developing diabetes mellitus type 2 in the future. It is essential to 
highlight the importance of adopting healthy habits during pregnancy in order to avoid con-
sequences for the future health of both the mother and the baby.
Gestational diabetes in twins is also associated with an increased risk of hypertensive dis-
orders, macrosomia, and preterm birth, but it reduces the risk for low birth weight [70]. 
Furthermore, it has been suggested that gestational diabetes could potentially benefit twin 
pregnancies, as low 5-min Apgar score and neonatal death are reduced in twins compared 
to singletons when this maternal complication is present, maybe due to the increased birth 
weight of the twin pairs [71, 72]. However, growth in the twin pair tends to be asymmetric 
when GDM or glucose intolerance is present [73].
Early diagnosis and treatment are essential in order to avoid complications during pregnancy. 
Nowadays, guidelines from different countries recommend the screening for gestational dia-
betes in women with risk factors such as previous history of gestational diabetes, obesity 
(body mass index over 30 kg/m2), and previous delivery of a macrosomic baby [74–76]. Some 
of them support the use of a universal screening test in the second trimester and also in the 
first trimester in every woman over the age of 35 [77]. However, the increase in maternal 
age over the last years implies offering this diagnostic test to a very high percentage of the 
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pregnant population [70]. Given the importance of early treatment, all twin pregnancies, as 
well as in the case of advanced maternal age, first trimester screening should be considered, 
although there is no international agreement [78].
5.4. Growth abnormalities
In mothers older than 40, small and large for gestational age babies and intrauterine growth 
restriction (IUGR) are increased [79, 80]. Small-for-gestational-age babies (SGA) and IUGR are 
assumed to be due to placental dysfunction, whose incidence increases with age.
One study found in a very large twin cohort that advanced maternal age was indirectly associ-
ated with SGA babies. However, when SGA was present in an older mother, neonatal mortal-
ity increased compared to appropriate-for-gestational-age twins in the same age range [81], 
maybe suggesting an increased severity of the syndrome in this women.
Although it may look as a contradiction, foetal macrosomia also seems to increase with age. 
It has been suggested that this increased incidence in large-for-gestational-age babies might 
be due to an overall increase in the body mass index with age [82] and an increased risk of 
gestational diabetes. However, as we previously mentioned, the increased birth weight in 
twin pregnancies associated with gestational diabetes could be beneficial for the twin pair, or 
at least not as detrimental as it could be in singletons.
5.5. Post-partum haemorrhage
Most protocols worldwide recognise maternal age as an independent risk factor for >10,000 mL 
blood loss during delivery and for post-partum haemorrhage, in both vaginal and caesarean 
births. Mechanisms behind this increased risk are not well established. Most doctors working in 
a labour ward are persuaded that uterine atony is somehow more common among older moth-
ers, although there is no evidence for that. Age is associated with certain obstetric complications, 
such as hypertensive disorders, placental abnormalities, or preterm birth. On the other hand, 
advanced maternal age increases the risk of induction of labour, large foetuses for gestational 
age, prolonged labour, oxytocin augmentation, or caesarean delivery. All of the above are well 
known risk factors of post-partum haemorrhage [83, 84]. So age may not act as a completely 
independent factor for post-partum haemorrhage. Results from the WOMAN trial showed an 
adjusted odds ratio of peripartum hysterectomy of 5.98 (95% CI: 3.34–10.70) for women between 
30 and 39 years and of 11.73 (95% CI: 6.30–21.85) for women aged ≥40 [85]. This is a trend shown 
to be repeated worldwide [86]. Advanced maternal age does not only increase the risk of exces-
sive bleeding but also its severity and the risk of needing aggressive treatment strategies, such 
as hysterectomy.
Again, twin pergnancy is also associated with a higher risk of post-partum haemorrhage. At 
the same time, twin pregnancy is often associated with other post-partum haemorrhage risk 
factors,  such as preeclampsia, caesarean delivery, and the use of a caesarean delivery for a 
preterm delivery [87]. Delivery in this group of patients should be undertaken in tertiary 
hospitals by trained staff.
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5.6. Venous thrombosis
The incidence of deep venous thrombosis is increased three times during pregnancy. Pulmonary 
embolism may occur in 1 in every 1000 pregnancies and represents the leading non-obstetrical 
cause of maternal death [88]. Both age older than 35 years and multiple pregnancy are listed 
as risk factors for venous thromboembolism. If we consider that the presence of thrombophilia 
is more common in women undergoing IVF and that deep venous thrombosis is also more 
common in these women [89, 90], we could conclude that women of advanced maternal age 
and carrying a multiple pregnancy definitely represent a high-risk group for venous thrombo-
embolism. Under any other risk factor, thromboprophylaxis should be considered carefully.
5.7. Stillbirth
Advanced maternal age has been associated with an increased incidence of stillbirth [91]. A 
mechanism under this increase is placental dysfunction, which accounts for around 65% of 
stillbirths, and it has been observed more frequently in mice models and humans with age. 
Placentas from older mothers (35–39 and ≥ 40 years old) are less efficient in the sense that 
foetal/placenta weight ratio was lower than placentas from controls under 30 years old. They 
seem to be bigger in size and display mechanisms to ameliorate function, like increased relax-
ation of myometrium arteries and increased amino acid transport, but this does not correlate 
with a higher birth weight in the offspring. The hypothesis is that an increased size could 
be an adaptive mechanism trying to make up for placental dysfunction [92]. It has also been 
suggested that the greater contribution to stillbirth in older mothers could arise from their 
increased risk of chromosomal abnormalities [80].
Twin pregnancies are also high risk for stillbirth and neonatal death, increasing thirteenfold 
in monochorionic and fivefold in dichorionic pregnancies compared to singletons [93, 94].
Although this is not under the scope of this chapter, advanced paternal age has also been 
associated with stillbirth and death of the child before 5 years of age [95, 96]. The risk might 
be linked to a higher rate of sperm chromatin or chromosomal aberrations. Interestingly, 
this association dissolves when adjusting for paternal education level, when the association 
between advanced maternal age and the risk of stillbirth is independent of socioeconomic and 
educational levels.
6. Delivery and post-partum care in twin pregnancies in advanced 
maternal age
6.1. Delivery mode and time of delivery
Advanced maternal age is associated with a high frequency of caesarean delivery. Many fac-
tors participate in this. For instances, a more frequent prolonged labour due to worse myome-
trial function and decreased flexibility of pelvic joints [97], increased frequency of large babies 
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[98, 99], and the presence of coexisting obstetrical or medical complications associated with 
poorer obstetric outcomes. However, most women over 40 have a successful vaginal delivery 
even after induction of labour without an increased risk for operative vaginal delivery or 
perineal trauma [100].
In dichorionic twin pregnancies, the perinatal risks are balanced with the risks associated with 
iatrogenic prematurity until 37 + 0–6 weeks’ gestation and until 36 + 0–6 in monochorionic 
pregnancies, with higher risks of stillbirths than neonatal deaths beyond this gestation [94].
Pre-labour caesarean delivery may be beneficial in pregnancies with the first twin in non-
cephalic presentation or when any or both the twins have a low weight, but evidence for both 
statements is not strong [100].
6.2. Post-partum care
When obstetric complications  such as preeclampsia or diabetes mellitus presented during 
pergnancy, persistence of medical conditions such as chronic hypertension and type 2 diabe-
tes (T2DM) should be monitored after delivery. Chronic hypertension in women affected by 
gestational hypertension or preeclampsia is a common event, usually developing years after 
delivery [101]. Age at pregnancy might reduce this time interval, but this has not been stud-
ied before. Likewise, age does not increase the odds of post-partum eclampsia [102]. Age at 
pregnancy is a risk factor for the development of T2DM when GDM is present [103]. Anyhow, 
advanced maternal age is a risk factor for developing cardiovascular complications during 
pregnancy and for developing severe morbidity due to cardiovascular disease [104], so strict 
and long-term follow-up strategies should be put in place.
Secondary post-partum haemorrhage is increased in women affected by primary post-partum 
haemorrhage and in women ≥35 years old, both risk factors being independently associated 
with the event [105].
Maternal age at delivery >35 years has been indicated as a risk factor for venous thromboem-
bolism in the post-partum period and later in life [106]. However, its contribution is probably 
small when compared to other factors, such as caesarean delivery [107].
Twin pregnancies are also associated with all the complications mentioned above. Again, this 
specific population is particularly vulnerable for developing post-partum complications.
Various studies suggest that advanced maternal age at the time of delivery is associated with 
a higher risk of developing stress urinary incompetence (SUI) in the post-partum period [108, 
109]. Suspected aetiological mechanisms are many and they are thought to start developing 
during pregnancy. Some studies suggest that vaginal delivery may worsen SUI, particularly 
in elderly women, and advise a caesarean delivery in this population when SUI is already 
present during pregnancy [108]. However, this protective effect is not consistent in literature, 
so currently, such a recommendation is controversial [110]. Of course, pelvic floor changes 
are greater in twin pregnancies, as abdominal pressure on it is irredeemably higher [111]. 
Anyhow, elderly mothers carrying a twin pregnancy are at higher risk of developing pel-
vic floor disorders, so preventive strategies should be enforced during pregnancy and early 
investigation and proper treatment in the post-partum period.
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Advanced maternal age is considered to be a risk factor for post-partum depression [112]. 
This is a poorly studied condition, which can be devastating for the mothers, children, and 
family. On the other hand, parents of twins frequently experience higher levels of anxiety and 
depression and are at higher risk for post-partum depression and for marital decline [113, 114]. 
Post-partum depression has also been linked to preterm birth, so common among twins, due 
to a lesser mother-infant interaction and parents’ concern for both medical and economic sub-
sequent issues [115]. Sleeping disorders 3 months post-partum are more frequent in mothers 
older than 35 years old [116]. Psychosocial and physical support should be provided.
7. Long-term disabilities due to advanced maternal age
Several neurological disorders have been shown to be more frequent in children born from 
elderly mothers, particularly cerebral palsy [117, 118] and autism spectrum disorders [119]. 
In terms of learning disabilities, one study found that developmental vulnerability decreases 
with the mother’s age from 15 to 30 years, but starts to increase when the mother is older than 
35, this increase being independent from the socioeconomic status [120]. Interestingly, chil-
dren born from old parents show a poorer neurocognitive performance in childhood [121]. 
However, environment might make up for the “biological disadvantage”, as older parents 
are usually in a better financial state, are more highly educated, and usually have reached a 
more stable couple/marriage situation. All this may give them certain emotional maturity and 
life experience that improves child-rearing abilities. Compared to singletons, twins exhibited 
higher rates of cerebral palsy and mental retardation and showed more pronounced speech 
delays, motor development, and behavioural problems. However, the main explaining factor 
is the higher frequency for preterm delivery that results in low and very low birth weight 
children [122]. Maternal age contributes by increasing the risk for preterm delivery, but the 
same way in singletons and twins.
Trisomy 21 is very well known to increase with maternal age due to meiotic non-disjunction 
errors. More recently, mitochondrial dysfunction and epigenetic changes associated with 
oocyte ageing can be inherited by the descendant and may predispose also to chromosome 
segregation errors in grandchildren [123].
8. Conclusions
Twin pregnancy in advanced reproductive age represents a very vulnerable population for 
obstetric and medical complication during and after pregnancy. Most of these pregnancies 
are a result of assisted reproduction. Counselling prior to treatment is essential, particularly 
to discern whether the woman is fit for pregnancy and to enforce specific preventive strate-
gies, such as single embryo transfer. Both conditions, advanced maternal age and twin preg-
nancy, are risk factors for many obstetric and medical complications. During pregnancy, early 
diagnosis and treatment of the issues discussed in this chapter can reduce risks and sequelae 
to the minimum.
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